Vascular Dementia Market Set to Reach $5.11 Billion by 2029 with 11.8% Yearly Growth

What combination of drivers is leading to accelerated growth in the vascular dementia market?
Advances in the vascular dementia market are anticipated due to the growing occurrence of cardiovascular disorders. Heart and blood vessel diseases, inclusive of conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension, constitute what is referred to as cardiovascular diseases. Factors contributing to the growing incidence of these diseases include unhealthy lifestyles, poor eating habits, lack of exercise, elevated stress levels, aging demographics, and an increase in risk factors such as obesity, diabetes, and hypertension. As cardiovascular disease impedes blood flow to the brain, it boosts the risk of vascular dementia, which can result in cognitive deterioration and damage to brain cells due to insufficient oxygen and nutrient supply. For instance, the British Heart Foundation, a UK-based cardiovascular research charity, stated in September 2024 that around 7.6 million people are currently living with heart and circulatory diseases in the UK, including 4 million men and 3.6 million women. These diseases account for nearly 27% of all UK deaths, culminating in over 170,000 annual fatalities, or about 480 every day, amounting to one death every three minutes. Thus, the escalating prevalence of cardiovascular diseases is propelling the vascular dementia market.

Get Your Vascular Dementia Market Report Here:
https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What is the projected compound annual growth rate (CAGR) of the vascular dementia market from 2025 to 2034, and what factors influence it?
There has been a rapid expansion in the market size of vascular dementia in recent years. The market is anticipated to augment from $2.92 billion in 2024 to $3.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.1%. The historical period expansion is associated with factors such as an escalation in healthcare spending, an increase in the count of vascular dementia patients diagnosed, a surge in the number of healthcare practitioners, development in public health programs, and an upsurge in cases of diabetes.

In the coming years, we anticipate a swift expansion of the vascular dementia market, growing at a compound annual growth rate (CAGR) of 11.8% to reach $5.11 billion by 2029. This growth is as a result of increased awareness of vascular dementia, enhanced healthcare investment, an aging population, a surge in cardiovascular disease prevalence, and an increase in high blood pressure occurrences. Some major trends for the forecasted period consist of technological innovation, customised care plans, telemedicine, gene therapy, and the incorporation of artificial intelligence.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

How are the latest trends influencing the growth of the vascular dementia market?
Leading businesses in the vascular dementia market are prioritizing the development of new treatments like multimodal therapies to maintain their market standing. Multimodal therapies involve a combination of different treatment strategies like medication, physical therapy, and mental health interventions, providing a comprehensive treatment for the condition. As an example, the Singapore-based biopharmaceutical firm Moleac unveiled an evidence-backed treatment specifically for vascular dementia (VaD), known as CognivAiD, in January 2023. This treatment blends active extracts from ginkgo, ginseng, and saffron, which have displayed substantial effects in slowing cognitive deterioration in patients with VaD. The distinctive multimodal effect of CognivAiD addresses crucial aspects of vascular dementia like vascular protection, vasoregulation, and neuroinflammation. Owing to its broad clinical trial support and strong safety profile, CognivAiD offers a promising new treatment option for VaD patients.

What are the major segments of the vascular dementia market and their role in driving growth?
The vascular dementia market covered in this report is segmented -

1) By Product: Monoclonal Antibodies, Small Molecules, Peptides
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998

Which regions are key players in the growth of the vascular dementia market?
North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the vascular dementia market?
Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam's Group of Hospitals, Alpha Cognition Inc., Citi Health

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

What Is Covered In The Vascular Dementia Global Market Report?

•Market Size Forecast: Examine the vascular dementia market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the vascular dementia market for a structured understanding.
•Key Players Overview: Analyze major players in the vascular dementia market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the vascular dementia market.
•Segment Contributions: Evaluate how different segments drive overall growth in the vascular dementia market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the vascular dementia market.
•Industry Challenges: Identify potential risks and obstacles affecting the vascular dementia market.
•Competitive Landscape: Review strategic developments in the vascular dementia market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.